Sex and gender

Topic

2016

Reporting Sex, Gender, or Both in Clinical Research?
Clayton JA, Tannenbaum C. JAMA. 2016 Nov 8;316(18):1863-1864. doi:10.1001/jama.2016.16405.
Sex, gender, clinical trials
Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use.
Heidari S, Babor TF, De Castro P, Tort S, Curno M. Research Integrity and Peer Review. 2016 May 3;1:2. doi:10.1186/s41073-016-0007-6.
Sex, gender, guidelines, scientific research, scientific publishing
Guidance on Gender Equality in Horizon 2020.
European Commission. Directorate-General for Research & Innovation. Version 2.0;22 April 2016.
Gender, equality, guide, Horizon 2020

2015

For a better integration of the gender dimension in Horizon 2020 Work Programme 2016-2017.
Horizon 2020 Advisory Group on Gender. Rev. 30 March 2015.
Gender, Horizon 2020

2014

Women and Asthma in the EU
European Institute of Women’s Health. October 2014.
Gender, asthma, policy, pregnancy

2013

Research policy: Only wholesale reform will bring equality.
Mühlenbruch B, Jochimsen MA. Nature. 2013 Mar 7;495(7439):40-2. doi:10.1038/495040a.
Gender, equality, policy, science
Women and Cardiovascular Disease in the EU
European Institute of Women’s Health. February 2013.
Gender, cardiovascular diseases, policy, pregnancy
Women and Diabetes in the EU
European Institute of Women’s Health. January 2013.
Gender, diabetes, cardiovascular diseases, policy, pregnancy

2011

Policy Brief #5: Gender Imbalances in Health Research.
The ENGENDER Project. October 2011.
Gender, research, equity, policy

2005

ICH - Gender Consideration In The Conduct Of Clinical Trials.
EMEA - European Medicines Agency. January 2005.
Gender, clinical trials, ICH guidelines

2003

Sex & Gender: The Politics, Policy, and Practice of Medical Research.
Keitt SK. Yale J Health Policy Law Ethics. 2003 Summer;3(2):253-78.
Sex, gender, research, clinical trials, policy, law

MMLAP and other EU Projects

AsiaFluCap Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia	BEWATER Making society an active participant in water adaptation to global change	CASI Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation	CIMULACT Engaging all of Europe in shaping a desirable and sustainable future	DARWIN Expect the unexpected and know how to respond
DRIVER Driving innovation in crisis management for European resilience	ECOM Effective communication in outbreak management: development of an evidence-based tool for Europe	EDEN Solutions to improve CBRNe resilience	EPISOUTH Network for Communicable Disease Control in Southern Europe and Mediterranean Countries	EPIWORK Developing the framework for an epidemic forecast infrastructure
EUPHARE Strengthening of the national surveillance system for communicable diseases	EUROHEP Surveillance of vaccine preventable hepatitis	EuroMOMO European monitoring of excess mortality for public health action	EURONHID European network for highly infectious disease	EUVAC.NET Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
FLUMODCONT Modelling the spread of pandemic influenza and strategies for its containment and mitigation	FLURESP Cost-effectiveness assessment of european influenza human pandemic alert and response strategies	GAP2 Bridging the gap between science, stakeholders and policy makers	HProImmune Promotion of immunization for health professionals in Europe	INPROFOOD Towards inclusive research programming for sustainable food innovations
JA-CHRODIS Addressing chronic diseases and healthy ageing across the life cycle	M-Eco Medical ecosystem – personalized event-based surveillance	MAPPING Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large	MARINA Get involved in the responsible marine research and innovation	PACITA Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
PANDEM Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas	PE2020 Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society	PERARES Public Engagement with Research And Research Engagement with Society	PHEME Computing Veracity – the Fourth Challenge of Big Data	PREPARE Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
PROMOVAX Promote vaccinations among migrant population in Europe	R&DIALOGUE Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society	RESPIRE Improve the quality of indoor air, keeping it free from radon	SATORI Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns	SECURING CITIES AGAINST GLOBAL PANDEMICS Investigating how cities in the West securitise against global pandemics
SEiSMiC Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe	SIS CATALYST Identifying how children can be change agents in the Science and Society relationship	SYN-ENERGENE Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks	TELLME Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence

Newsletters

Select the newsletter(s) to which you want to subscribe or unsubscribe.

Contacts

Contacts

General inquiries: info@asset-scienceinsociety.eu

ASSET

Action plan on Science in Society related issues in Epidemics and Total pandemics

European Commission

This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 612236.